Skip to main content
BriaCell Therapeutics Corp. (TSX:BCT)
Canada flag Canada · Delayed Price · Currency is CAD
5.07
-0.10 (-1.93%)
At close: Mar 9, 2026

BriaCell Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
 TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Oct '25 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21 2020 - 2016
Net Income
-28.71-26.31-4.79-20.3-26.84-13.82
Upgrade
Depreciation & Amortization
0.110.110.080.020.020.02
Upgrade
Loss (Gain) on Equity Investments
0.20.220.11---
Upgrade
Stock-Based Compensation
0.80.781.82.193.071.97
Upgrade
Other Operating Activities
-1.75-1.06-28.38-2.1211.666.36
Upgrade
Change in Accounts Receivable
0.730.73-0.730.01-0.010.01
Upgrade
Change in Accounts Payable
-2.11-3.896.050.660.25-1.41
Upgrade
Change in Other Net Operating Assets
1.81.251.74-4.2-0.63-0.89
Upgrade
Operating Cash Flow
-28.92-28.17-24.13-23.74-12.48-7.75
Upgrade
Capital Expenditures
---0.46---
Upgrade
Investment in Securities
-7.65-7.65-0.23---
Upgrade
Investing Cash Flow
-7.65-7.65-0.68---
Upgrade
Short-Term Debt Issued
-----0.22
Upgrade
Total Debt Issued
-----0.22
Upgrade
Short-Term Debt Repaid
------0.55
Upgrade
Total Debt Repaid
------0.55
Upgrade
Net Debt Issued (Repaid)
------0.33
Upgrade
Issuance of Common Stock
33.4945.454.4246.5165.33
Upgrade
Repurchase of Common Stock
----0.05-10.17-
Upgrade
Other Financing Activities
-----0.08-
Upgrade
Financing Cash Flow
33.4945.454.423.95-3.7465
Upgrade
Net Cash Flow
-3.089.63-20.39-19.79-16.2357.25
Upgrade
Free Cash Flow
-28.92-28.17-24.58-23.74-12.48-7.75
Upgrade
Free Cash Flow Per Share
-34.04-66.58-224.09-228.03-120.86-257.22
Upgrade
Levered Free Cash Flow
-18.51-18.89-10.83-15.87-6.86-5.83
Upgrade
Unlevered Free Cash Flow
-18.49-18.87-10.83-15.87-6.86-5.78
Upgrade
Change in Working Capital
0.43-1.917.05-3.53-0.39-2.28
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.